JPWO2020002540A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020002540A5
JPWO2020002540A5 JP2020573481A JP2020573481A JPWO2020002540A5 JP WO2020002540 A5 JPWO2020002540 A5 JP WO2020002540A5 JP 2020573481 A JP2020573481 A JP 2020573481A JP 2020573481 A JP2020573481 A JP 2020573481A JP WO2020002540 A5 JPWO2020002540 A5 JP WO2020002540A5
Authority
JP
Japan
Prior art keywords
exosome
cells
lipid
modified rna
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020573481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528096A (ja
JP2021528096A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/067232 external-priority patent/WO2020002540A1/en
Publication of JP2021528096A publication Critical patent/JP2021528096A/ja
Publication of JP2021528096A5 publication Critical patent/JP2021528096A5/ja
Publication of JPWO2020002540A5 publication Critical patent/JPWO2020002540A5/ja
Priority to JP2024034020A priority Critical patent/JP2024081661A/ja
Pending legal-status Critical Current

Links

JP2020573481A 2018-06-28 2019-06-27 エキソソーム細胞外小胞及びその使用方法 Pending JP2021528096A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024034020A JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862691348P 2018-06-28 2018-06-28
US62/691,348 2018-06-28
PCT/EP2019/067232 WO2020002540A1 (en) 2018-06-28 2019-06-27 Exosome extracellular vesicles and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024034020A Division JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Publications (3)

Publication Number Publication Date
JP2021528096A JP2021528096A (ja) 2021-10-21
JP2021528096A5 JP2021528096A5 (https=) 2022-07-04
JPWO2020002540A5 true JPWO2020002540A5 (https=) 2022-07-04

Family

ID=67139730

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573481A Pending JP2021528096A (ja) 2018-06-28 2019-06-27 エキソソーム細胞外小胞及びその使用方法
JP2024034020A Pending JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024034020A Pending JP2024081661A (ja) 2018-06-28 2024-03-06 エキソソーム細胞外小胞及びその使用方法

Country Status (5)

Country Link
US (1) US12109310B2 (https=)
EP (1) EP3813798A1 (https=)
JP (2) JP2021528096A (https=)
CN (1) CN112543629A (https=)
WO (1) WO2020002540A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
CN113271926A (zh) 2018-09-20 2021-08-17 摩登纳特斯有限公司 脂质纳米颗粒的制备及其施用方法
KR20230167008A (ko) * 2020-08-06 2023-12-07 모더나티엑스, 인크. 지질 나노입자의 제조 방법
JP7633787B2 (ja) * 2020-09-23 2025-02-20 三洋化成工業株式会社 細胞外小胞の製造方法
JP2023546175A (ja) 2020-10-14 2023-11-01 ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド 脂質ナノ粒子製造の方法及びそれに由来する組成物
WO2023178500A1 (en) * 2022-03-22 2023-09-28 Beijing Theraxyte Bioscience Co. Ltd. Therapeutic vesicles and methods of processing the same
CN114848608B (zh) * 2022-05-17 2024-01-30 东南大学 一种蛋白或多肽递送载体及其制备方法与应用
CN115887758B (zh) * 2022-11-15 2024-01-26 西南交通大学 负载外泌体促进糖尿病创面修复的共聚水凝胶
CN117679354B (zh) * 2024-02-04 2024-05-28 知想(山东)医疗科技有限公司 金花茶外泌体制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3569254B1 (en) * 2009-04-17 2022-07-20 Oxford University Innovation Limited Composition for delivery of genetic material
JP2010285426A (ja) * 2009-05-11 2010-12-24 National Cancer Center 核酸導入方法
MX342785B (es) 2009-06-10 2016-10-12 Alnylam Pharmaceuticals Inc Formulacion mejorada de lipido.
CA2805265A1 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
US8691750B2 (en) 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
CN104114572A (zh) * 2011-12-16 2014-10-22 现代治疗公司 经修饰的核苷、核苷酸和核酸组合物
EA037503B1 (ru) 2014-01-21 2021-04-05 Анджариум Байосайенсиз Аг Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
SMT202200502T1 (it) 2014-06-25 2023-01-13 Acuitas Therapeutics Inc Nuovi lipidi e formulazioni di nanoparticelle lipidiche per l'erogazione di acidi nucleici
US11219634B2 (en) * 2015-01-21 2022-01-11 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
US20210290556A1 (en) * 2016-08-22 2021-09-23 Codiak Biosciences, Inc. Methods of suppressing delivery of exosomes to liver and spleen
EP3292861A1 (en) * 2016-09-13 2018-03-14 Centre National De La Recherche Scientifique (Cnrs) An in vitro method for obtaining a biohybrid vector

Similar Documents

Publication Publication Date Title
JP2021528096A5 (https=)
JP7600208B2 (ja) 拘束された脂質を含むナノ材料およびその使用
Merkel et al. Nonviral siRNA delivery to the lung: Investigation of PEG− PEI polyplexes and their in vivo performance
CN108368028B (zh) 用于递送核酸的新型脂质和脂质纳米颗粒制剂
KR20210135494A (ko) 지질 나노입자의 제조 방법
Zeng et al. Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery
CN114269360A (zh) 用于治疗递送的平台、组合物和方法
KR101870316B1 (ko) 음이온성 약물을 함유하는 고분자 미셀의 제조방법
TW201534578A (zh) 新穎脂質
US20240148794A1 (en) Lnp compositions comprising payloads for in vivo therapy
CN118414429A (zh) Rna构建体及其用途
JPWO2020002540A5 (https=)
CN114404391B (zh) 一种纳米粒及其制备方法和用途
US10561741B2 (en) Nanoparticle conjugates and uses thereof
EP3675871A1 (en) Compositions and methods for the treatment of fibrotic diseases
CN119300865A (zh) 用于中枢神经系统递送的脂质纳米颗粒制剂
CN119654141A (zh) 脂质纳米颗粒的组合物
CN120092014A (zh) Rna构建体和其用途
WO2023036148A1 (zh) 一类阳离子脂质化合物及其应用
CN111867634B (zh) 使用藻酸酯低聚物增强微米/纳米颗粒跨粘液层的易位
JPWO2021202772A5 (https=)
TW201726614A (zh) 作為陽離子性脂質之化合物
JPWO2021158996A5 (https=)
WO2025079599A1 (ja) サブセットレベルで細胞を標的化可能な担体およびその製造方法
US11364305B2 (en) Nanoparticle conjugates and uses thereof